Traders Alert: Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), J.C. Penney Company, Inc. (NYSE:JCP), Arch Coal Inc (NYSE:ACI)
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) moved up 0.71% to $8.56 on a traded volume of 1.98 million shares. Astex Pharmaceuticals, Inc. announced that detailed clinical responses and biomarkers data of relapsed/refractory AML patients treated in the Phase 1 part of the SGI-110-01 study were presented at the European Cancer Congress in Amsterdam, Netherlands. The presentation showed that of the 50 heavily pre-treated Phase 1 AML patients with LINE-1 DNA methylation data, there were 5 Complete Responses, or 10%.
How Should Investors Trade ASTX After The Recent Volatility? Get Free Report Here
J.C. Penney Company, Inc. (NYSE:JCP) augmented 1.71% to $8.90 on a traded volume of 11.38 million shares. Robbins Geller Rudman & Dowd LLP announced that a class action has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of J.C. Penney Company, Inc. common stock during the period between August 20, 2013 and September 26, 2013.
Should Investors Buy JCP After Yesterday’s Slump? Find Out Here
Arch Coal Inc (NYSE:ACI) declined 0.25% to $4.01 on a traded volume of 2.75 million shares. Goldman Sachs started coverage on Arch Coal Inc with a sell rating from neutral and the price target at $3. Arch Coal, Inc. is the coal producer. The Company sells substantially all of its coal to power plants, steel mills and industrial facilities. As of December 31, 2012, it operated, or contracted out the operation of, 32 active mines located in each of the coal-producing regions of the United States.